Maura Nicolosi

Citta, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).

Journal: HemaSphere
Published: September 08, 2025

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Journal: HemaSphere
Published: July 22, 2025

Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia.

Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia.

Journal: HemaSphere
Published: November 22, 2024

Bispecific Antibodies for Lymphoid Malignancy Treatment.

Bispecific Antibodies for Lymphoid Malignancy Treatment.

Journal: Cancers
Published: October 14, 2024

Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care).

Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care).

Journal: Leukemia & lymphoma
Published: June 07, 2024

Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice.

Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice.

Journal: Cancers
Published: April 06, 2024

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi.

Journal: Frontiers in oncology
Published: December 10, 2022

Precision Medicine in Systemic Mastocytosis.

Precision Medicine in Systemic Mastocytosis.

Journal: Medicina (Kaunas, Lithuania)
Published: September 21, 2021

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms.

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms.

Journal: Frontiers in oncology
Published: September 15, 2021

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists.

Journal: International journal of molecular sciences
Published: February 01, 2021

A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.

A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.

Journal: BMC geriatrics
Published: November 24, 2020

Atypical Chronic Myeloid Leukemia: Where Are We Now?

Atypical Chronic Myeloid Leukemia: Where Are We Now?

Journal: International journal of molecular sciences
Published: July 26, 2020
Showing 1-12 of 43

Last Updated: 09/26/2026